19th WorldMEN Meeting
  1. Início

Programação

Filtrar atividades
Sala 1
07:45 - 08:00
Welcome

Introduction

Sala 1
08:00 - 08:40
Plenary Session

Effective tools to expand worldwide collaborations. Examples of effective alliances.

Sala 1
08:40 - 10:10
Symposium

Paraganglioma/Pheochromocytoma

08:40 - 08:50
Unmet needs
08:50 - 09:10
Update on molecular features of paragangliomas
09:10 - 09:30
Personalized management of pheochromocytomas and paragangliomas
09:30 - 09:50
Systemic treatment of metastatic pheochromocytomas and paragangliomas
09:50 - 10:10
Discussion
Sala 1
10:10 - 10:40
Coffee Break

Poster Discussions

Sala 1
10:40 - 12:10
Symposium

Pituitary

10:40 - 10:50
Unmet needs
10:50 - 11:05
Genetics of familial isolated pituitary tumors
11:05 - 11:20
Genetics of pediatric pituitary tumors
11:20 - 11:35
Consensus guidelines for the diagnosis and management of pituitary adenomas in childhood and adolescence – a summary
11:35 - 11:50
New targets for therapeutic approach of aggressive PitNETs: is there a place for immunotherapy, themozolamide?
11:50 - 12:10
Discussion
Sala 1
12:10 - 12:40
Sponsored Lecture

Lilly | The role of RET inhibitors in the treatment of advanced thyroid cancers

Sala 1
12:40 - 13:40
Lunch

Poster Discussions

Sala 1
13:40 - 14:25
Oral Presentations

.

13:40 - 13:50
1
13:50 - 13:55
Discussion
13:55 - 14:05
2
14:05 - 14:10
Discussion
14:10 - 14:20
3
14:20 - 14:25
Discussion
Sala 1
14:25 - 15:55
Symposium

MEN2

14:25 - 14:35
Unmet needs
14:35 - 14:55
A critical review of the 2015 ATA Risk Stratification of RET mutations and timing for prophylactic thyroidectomy. Time for change?
14:55 - 15:15
Updates on the genetics and histopathological grading of MTC
15:15 - 15:35
Advanced MTC – Discussing long-term experiences with MKIs and RET inhibitors. Can we define a treatment sequence protocol?
15:35 - 15:55
Discussion
Sala 1
15:55 - 16:30
Coffee Break

Poster Discussions

Sala 1
16:30 - 17:30
Panel

New American Thyroid Association Guideline for Advanced Medullary Thyroid Cancer

Sala 1
17:30 - 18:15
Symposium

Advances in Bilateral Macronodular Adrenocortical Disease (BMAD)

17:30 - 17:50
A Global Approach to the Long-Term follow-up of 17 Brazilian Families with Bilateral Macronodular Adrenal Disease
17:50 - 18:10
The role of KDM1A and other genetic alterations associated with BMAD
18:10 - 18:15
Discussion
Sala 1
08:00 - 09:30
Symposium

Parathyroid Diseases

08:00 - 08:15
The FIRMO parathyroid medal
08:15 - 08:30
PHPT - advances in diagnosis and management
08:30 - 08:45
Genetics of parathyroid neoplasia
08:45 - 09:00
Advances in the treatment of post-surgical hypoparathyroidism
09:00 - 09:15
Parathyroid cancer – MD Anderson experience
09:15 - 09:30
Discussion
Sala 1
09:30 - 10:05
Coffee Break

Poster Discussions

Sala 1
10:05 - 11:20
Symposium

Pancreatic NET

10:05 - 10:15
Unmet needs
10:15 - 10:30
Predicting and preventing PNETs
10:30 - 10:45
Surgical management of PNETs in MEN1
10:45 - 11:00
The role of precision medicine in the management of advanced PNETS
11:00 - 11:20
Discussion
Sala 1
11:20 - 12:20
Symposium

Treatment of Pancreatic Neuroendocrine Tumors – Beyond traditional surgery and targeted therapy

11:20 - 11:35
PNET: Radionuclide therapy and developing novel models of NETs to enable discovery
11:35 - 11:50
A new era in management of PNETs
11:50 - 12:05
Update in liver transplantation for metastatic PNET
12:05 - 12:20
Discussion
Sala 1
12:20 - 13:20
Lunch

Poster Discussions

Sala 1
13:20 - 14:00
Sponsored Lecture

Targeting HIF pathway in tumors associated to VHL syndrome

13:20 - 14:00
Targeting HIF pathway in tumors associated to VHL syndrome
Sala 1
14:00 - 15:30
Symposium

MEN 1

14:00 - 14:10
Unmet needs
14:10 - 14:30
Update in genetics of MEN1
14:30 - 14:50
The role of epigenetics in PNET development and as a potential therapeutic target
14:50 - 15:10
Unilateral clearance versus subtotal or total parathyroidectomy
15:10 - 15:30
Discussion
Sala 1
15:30 - 16:00
Coffee Break

Poster Discussions

Sala 1
16:00 - 16:45
Oral Presentations

.

16:00 - 16:10
1
16:10 - 16:15
Discussion
16:15 - 16:25
2
16:25 - 16:30
Discussion
16:30 - 16:40
3
16:40 - 16:45
Discussion
Sala 1
16:45 - 17:45
Plenary Session

MEN1 Guidelines

Sala 1
17:45 - 18:00
Meeting Summary

Perspectives

Sala 1
18:00 - 18:15
Meeting Adjournment

Conclusions